Long-term calcitonin therapy in postmenopausal osteoporosis.

[1]  H. DeLuca.  The kidney as an endocrine organ involved in the function of vitamin D. , 1975, The American journal of medicine.

[2]  A. Tashjian,et al.  Immunoassay of human calcitonin. , 1970, The New England journal of medicine.

[3]  M. Glimcher,et al.  Collagen synthesis and degradation in embryonic chick-bone explants. , 1979, The Journal of bone and joint surgery. American volume.

[4]  H. E. Palmer,et al.  Measurement of total body calcium (bone mass) in vivo with the use of total body neutron activation analysis. , 1970, The Journal of laboratory and clinical medicine.

[5]  Martin Tj.  The therapeutic uses of calcitonin. , 1978 .

[6]  J. Jowsey,et al.  Secondary hyperparathyroidism produced in kittens repeatedly given porcine calcitonin. , 1971, Endocrinology.

[7]  R. O'dor,et al.  A study of the stability of calcitonin biological activity. , 1973, Endocrinology.

[8]  G. W. Snedecor.  Statistical Methods , 1964 .

[9]  C. Arnaud,et al.  Radioimmunoassay of human parathyroid hormone in serum. , 1971, The Journal of clinical investigation.

[10]  G. Gleser,et al.  Estimation of stature from long bones of American Whites and Negroes. , 1952, American journal of physical anthropology.

[11]  C. Gennari,et al.  Calcium metabolism and 47calcium kinetics before and after long-term thyrocalcitonin treatment in senile osteoporosis. , 1970, Clinical science.

[12]  H. Rasmussen,et al.  Effect of combined therapy with phosphate and calcitonin on bone volume in osteoporosis , 1980 .

[13]  P. Kelly,et al.  Effects of prolonged administration of porcine calcitonin in postmenopausal osteoporosis. , 1971, The Journal of clinical endocrinology and metabolism.

[14]  H. E. Palmer,et al.  Absolute measurement of total body calcium (bone mass) in vivo. , 1972, The Journal of laboratory and clinical medicine.

[15]  S. Udenfriend,et al.  A specific method for the analysis of hydroxyproline in tissues and urine. , 1960, Analytical biochemistry.

[16]  P. Kelly,et al.  Calcium and salmon calcitonin in treatment of osteoporosis. , 1978, The Journal of clinical endocrinology and metabolism.

[17]  S. Wallach.  Treatment of Paget's disease. , 1982, Advances in internal medicine.

[18]  L. Raisz,et al.  Escape from inhibition or resorption in cultures of fetal bone treated with calcitoninand parathyroid hromone. , 1972, Endocrinology.

[19]  S. Krane,et al.  Urinary polypeptides related to collagen synthesis. , 1970, The Journal of clinical investigation.

[20]  L. Mallette.  Sensitivity of the antibovine parathyroid hormone serum 211/32 to synthetic fragments of human parathyroid hormone. , 1980, The Journal of clinical endocrinology and metabolism.

[21]  J A Sorenson,et al.  Precision and accuracy of bone mineral determination by direct photon absorptiometry. , 1968, Investigative radiology.

[22]  W. Nelp,et al.  Relationship between local and total bone mass in osteoporosis. , 1975, Metabolism: clinical and experimental.

[23]  S. Krane,et al.  An evaluation of antibodies and clinical resistance to salmon calcitonin. , 1972, The Journal of clinical investigation.

[24]  H. Heath,et al.  Calcitonin: physiology and pathophysiology. , 1981, The New England journal of medicine.

[25]  J. Wergedal,et al.  Quantitative histological studies on the pathogenesis of uremic bone disease. , 1974, The Journal of clinical endocrinology and metabolism.

[26]  H. Atkins,et al.  Effects of porcine calcitonin on calcium metabolism in osteoporosis. , 1971, The Journal of clinical endocrinology and metabolism.

[27]  M. Haussler,et al.  Increased serum 1,25-dihydroxyvitamin D in idiopathic hypercalciuria. , 1977, The Journal of laboratory and clinical medicine.

[28]  J. Wergedal,et al.  Regulation of serum 1alpha,25-dihydroxyvitamin D3 by calcium and phosphate in the rat , 1975, Science.

[29]  A. Tashjian,et al.  Calcitonin binding sites in bone: relationships to biological response and "escape". , 1978, Recent progress in hormone research.

[30]  D. Fraser,et al.  Regulation of 25-hydroxycholecalciferol-1-hydroxylase activity in kidney by parathyroid hormone. , 1973, Nature: New biology.

[31]  O. H. Sørensen,et al.  THE RENAL EFFECT OF CALCITONIN IN HYPOPARATHYROID PATIENTS , 1972, Acta medica Scandinavica.

[32]  J. Talbot,et al.  Calcitonin treatment of post-menopausal osteoporosis. Evaluation of efficacy by principal components analysis. , 1975, Biomedicine / [publiee pour l'A.A.I.C.I.G.].

[33]  I. Macintyre,et al.  Effect of Calcitonin on Vitamin D Metabolism , 1972, Nature.